Sanofi signs collaboration agreement with Schneider Electric to accelerate its energy efficiency program on its industrial

PR Newswire/Les Echos/ 
PRESS RELEASE 
Sanofi signs collaboration agreement with Schneider Electric to accelerate its
energy efficiency program on its industrial sites 
Paris and Rueil-Malmaison, France - March 28, 2013 - Sanofi (EURONEXT: SAN and
NYSE: SNY) and Schneider Electric today announced the signing of a collaboration
agreement as part of Sanofi's energy performance optimization program for its
industrial sites in 40 countries around the world. 
"It's an important step for Sanofi to collaborate on a global scale with
Schneider Electric, a leader in energy management," explains Philippe Luscan,
Sanofi's Senior Vice President for Industrial Affairs. "This industrial
collaboration will enhance the energy efficiency program developed throughout
Sanofi's global network of manufacturing sites. These efforts currently have
enabled us to be ahead of our objective to reduce direct and indirect emissions
of CO2 to 20 percent below 2010 values by 2020." 
"Schneider Electric is delighted to be actively supporting Sanofi in improving
energy management on its industrial sites," said Laurent Vernerey, Schneider
Electric's Vice President for End User Business Group. "This collaboration
illustrates Schneider Electric's unique capability to provide its customers with
integrated and global solutions that value energy as a major asset for a
company." 
The collaboration will operate employing four components: the establishment of
an Energy Observatory to assist Sanofi with forecasting energy price changes in
16 countries; energy performance monitoring both globally and per site using the
Struxureware Energy Operation software; on-site diagnostics to contribute
towards the design of energy efficiency improvement plans; and energy
consultancy to Sanofi's engineering teams starting from the design phase of any
new industrial site. 
To support Sanofi in this collaboration, Schneider Electric will base its
strategy on experience acquired since 2005 from its Energy Action program for
the continuous reduction of energy consumption on Schneider Electric sites
around the world. 
The Sanofi - Schneider Electric collaboration agreement is implemented for three
years. 
About Sanofi
Sanofi is a diversified world leader in healthcare, researching, developing and
marketing therapeutic solutions based on patient needs. Sanofi has fundamental
advantages in the health sector with seven major growth areas: diabetes
management, human vaccines, innovative products, consumer healthcare, emerging
markets, animal health and the new Genzyme. Sanofi is quoted in Paris (Euronext:
SAN) and in New York (NYSE: SNY). 
About Schneider Electric
As a global specialist in energy management with operations in more than 100
countries, Schneider Electric offers integrated solutions across multiple market
segments, including leadership positions in Utilities & Infrastructure,
Industries & Machines Manufacturers, Non-residential Building, Data Centres &
Networks and in Residential. Focused on making energy safe, reliable, efficient,
productive and green, the Group's 140,000 plus employees achieved sales of 24
billion euros in 2012, through an active commitment to help individuals and
organizations make the most of their energy.
www.schneider-electric.com 
Contacts: 
Sanofi 
Media Relations                       
Frédéric Lemonde-San            
Phone: + (33) 1 53 77 46 46            
Email: frederic.lemonde@sanofi.com   
Schneider Electric 
Media Relations                   
Véronique Roquet-Montegon     
Phone: + (33) 1 41 29 70 76     
Email: veronique.roquet-montegon@schneider-electric.com  
Investor Relations
Sébastien Martel
Phone: + (33) 1 53 77 45 45
Email: ir@sanofi.com 
Investor Relations
Anthony Song
Phone: + (33) 1 41 29 83 29
Email: anthony.song@schneider-electric.com 
                  
The content and accuracy of news releases published on this site and/or 
distributed by PR Newswire or its partners are the sole responsibility of the 
originating company or organisation. Whilst every effort is made to ensure the 
accuracy of our services, such releases are not actively monitored or reviewed 
by PR Newswire or its partners and under no circumstances shall PR Newswire or 
its partners be liable for any loss or damage resulting from the use of such 
information. All information should be checked prior to publication. 
-0- Mar/28/2013 08:30 GMT